Why insider trading matters?

When insiders buy shares on the open market, this can thus be regarded as a strong endorsement by those that know the company the best -- they are literally betting their own money on the company's future. Insider selling, however, is not necessarily meaningful in any way, as there is a range of reasons for insiders to liquidate (some) of the shares they own.

- Seeking Alpha
Akero Therapeutics, Inc. (AKRO)
Sector: Healthcare; Industry: Biotechnology

Akero Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development and commercialization of treatments for serious metabolic diseases. Akero Therapeutics, Inc. was founded in 2017 and is headquartered in South San Francisco, California.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2021-04-01 Young Jonathan Chief Operating Officer Sell 3,055 $28.75 $87,828 No
2021-04-01 White William Richard Chief Financial Officer Sell 50,000 $28.64 $1,432,166 Yes
2021-03-01 Young Jonathan Chief Operating Officer Sell 3,055 $30.48 $93,112 No
2021-02-01 Young Jonathan Chief Operating Officer Sell 3,055 $29.24 $89,321 No
2021-01-08 Young Jonathan Chief Operating Officer Sell 10,000 $28.12 $281,200 Yes
2021-01-04 Young Jonathan Chief Operating Officer Sell 3,060 $25.29 $77,399 No
2020-10-09 Bitterman Kevin Director Sell 13,000 $28.93 $376,090 No
2020-07-10 Apple Tree Partners IV, L.P. 10%-Owner Buy 415,000 $36.00 $14,940,000 No
2020-07-10 Harrison Seth Loring 10%-Owner, Director Buy 415,000 $36.00 $14,940,000 No
2020-01-09 Versant Venture Capital VI, L.P. 10%-Owner Sell 53,057 $19.99 $1,060,845 No
2020-01-06 Versant Venture Capital VI, L.P. 10%-Owner Sell 72,444 $19.70 $1,427,272 No
2020-07-06 venBio Global Strategic Fund II L.P. 10%-Owner Sell 116,467 $34.40 $4,006,537 No
2020-03-06 venBio Global Strategic Fund II L.P. 10%-Owner Sell 45,950 $23.76 $1,091,608 No
2020-03-03 venBio Global Strategic Fund II L.P. 10%-Owner Sell 21,798 $22.63 $493,310 No
2020-02-27 venBio Global Strategic Fund II L.P. 10%-Owner Sell 5,904 $22.80 $134,635 No
2020-02-12 venBio Global Strategic Fund II L.P. 10%-Owner Sell 10,026 $27.07 $271,399 No
2020-02-06 venBio Global Strategic Fund II L.P. 10%-Owner Sell 6,102 $27.03 $164,955 No
2020-02-05 venBio Global Strategic Fund II L.P. 10%-Owner Sell 82,339 $25.77 $2,121,726 No
2020-01-21 Versant Venture Capital VI, L.P. 10%-Owner Sell 59,532 $20.87 $1,242,403 No
2020-01-15 Versant Venture Capital VI, L.P. 10%-Owner Sell 50,837 $20.04 $1,018,571 No
2020-01-13 venBio Global Strategic Fund II L.P. 10%-Owner Sell 494,000 $20.23 $9,993,620 No
2020-01-08 venBio Global Strategic Fund II L.P. 10%-Owner Sell 15,677 $19.86 $311,355 No
2020-01-09 Versant Venture Capital VI, L.P. 10%-Owner Sell 53,057 $19.99 $1,060,845 No
2020-01-07 venBio Global Strategic Fund II L.P. 10%-Owner Sell 73,221 $19.86 $1,454,530 No
2020-01-06 Versant Venture Capital VI, L.P. 10%-Owner Sell 72,444 $19.70 $1,427,272 No
2020-01-03 venBio Global Strategic Fund II L.P. 10%-Owner Sell 35,498 $19.71 $699,721 No
2019-12-31 venBio Global Strategic Fund II L.P. 10%-Owner Sell 14,324 $23.96 $343,259 No
2019-12-31 Versant Venture Capital VI, L.P. 10%-Owner Sell 389,382 $24.20 $9,421,175 No
2019-12-31 Versant Venture Capital VI, L.P. 10%-Owner Sell 389,382 $24.20 $9,421,175 No
2019-12-26 Versant Venture Capital VI, L.P. 10%-Owner Sell 49,220 $21.34 $1,050,416 No

Insider Smart

PENN NATIONAL GAMING INC (PENN) - PENN took a deep dive from $36 to $5 due to the crash, anyone who was bold enough to pick up some shares in March or April could have made a 900% profit in 2 months. But bottom fishing is always easier said than done, if one took a safer bet and followed multiple insider buying around $18, a 100% profit is still impressive.

Insider Smart

Axsome Therapeutics, Inc (AXSM) - AXSM shows the power of an #allgreen stock, no insider selling, great management great company, if you follow the insiders last year and pick up around $25, the 52 week high is $100+.